Inhibrx Biosciences, Inc. Common Stock

INBXNASDAQ • USD
77.66 USD
↘ 5.64 (6.77%)AT CLOSE (03:59 PM EST)
77.50
↘ 0.16 (0.21%)
POST MARKET (AS OF 07:32 PM EST)
Post Market
AS OF 07:32 PM EST
77.50
↘ 0.16 (0.21%)
🔴Market: CLOSED

INBX is currently priced at $77.73. Technical and fundamental signals converge bearish — technicals rate "Strong Sell" while fundamentals read "Sell". Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (260.8%) and a bearish Death Cross on the long-term moving averages.

Technical & fundamental data as of Nov 16, 2026.

Open?$80.28
High?$84.71
Low?$76.50
Prev. Close?$83.30
Volume?286.0K
Avg. Volume?268.9K
VWAP?$78.82
Rel. Volume?1.06x
Bid / Ask
Bid?$60.00 × 100
Ask?$95.00 × 100
Spread?$35.00
Midpoint?$77.50
Valuation & Ratios
Market Cap?1.2B
Shares Out?14.7M
Float?9.6M
Float %?65.5%
P/E Ratio?N/A
P/B Ratio?-23.14
EPS?-$9.39
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.
Employees
110
Market Cap
1.2B
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
2024-05-28
Address
11025 N. TORREY PINES ROAD, SUITE 140
LA JOLLA, CA 92037
Phone: (858) 795-4220
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
23
Short Sent.?
10
Piotroski F-Score?0/9Weak
Altman Z-Score?-1.17Distress
Confidence?69%Moderate
Full Fundamental Analysis →
Short InterestSqueeze Risk
Short % of Float?35.17%Squeeze Risk
Short Interest?3.4M
Days to Cover?10.0
Free Float9.6M
Avg Daily Volume339.1K
Settlement Date2026-10-30
Financial Health
Current Ratio?5.07Strong
Quick Ratio?5.07Strong
Cash Ratio?4.75Strong
Debt/Equity?-3.33Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
S&P
97
-23.14CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-10.1CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
Peers
50
S&P
97
260.8%STRONG▾
ROA?
S&P
3
-89.6%WEAK▾
Cash Flow & Enterprise
FCF?$-131899000
Enterprise Value?$1.3B
Fundamentals ratios updated end of day